Literature DB >> 2829674

Enalapril for pregnancy-induced hypertension: acute renal failure in a neonate.

G Schubiger1, G Flury, J Nussberger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2829674     DOI: 10.7326/0003-4819-108-2-215

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  12 in total

1.  Congenital renal tubular dysplasia and skull ossification defects similar to teratogenic effects of angiotensin converting enzyme (ACE) inhibitors.

Authors:  D Kumar; G Moss; R Primhak; R Coombs
Journal:  J Med Genet       Date:  1997-07       Impact factor: 6.318

Review 2.  Taking ACE inhibitors during pregnancy. Is it safe?

Authors:  Savithiri Ratnapalan; Gideon Koren
Journal:  Can Fam Physician       Date:  2002-06       Impact factor: 3.275

3.  Successful pregnancy with scleroderma renal disease and pulmonary hypertension in a patient using angiotensin converting enzyme inhibitors.

Authors:  B A Baethge; R E Wolf
Journal:  Ann Rheum Dis       Date:  1989-09       Impact factor: 19.103

4.  Clinical quiz. What is the cause of anuria in this newborn infant?

Authors:  B Hoppe; T Neuhaus; B Weisser; E Leumann
Journal:  Pediatr Nephrol       Date:  1993-12       Impact factor: 3.714

Review 5.  An overview of the influence of ACE inhibitors on fetal-placental circulation and perinatal development.

Authors:  H S Buttar
Journal:  Mol Cell Biochem       Date:  1997-11       Impact factor: 3.396

Review 6.  Adverse effects of angiotensin converting enzyme (ACE) inhibitors. An update.

Authors:  R C Parish; L J Miller
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

7.  Enalapril-induced acute renal failure in a newborn infant.

Authors:  Sourabh Dutta; Anil Narang
Journal:  Pediatr Nephrol       Date:  2003-04-16       Impact factor: 3.714

8.  Comparison of the transplacental transfer of enalapril, captopril and losartan in sheep.

Authors:  K M Stevenson; K J Gibson; E R Lumbers
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

Review 9.  Pharmacokinetic optimisation of angiotensin converting enzyme (ACE) inhibitor therapy.

Authors:  M Burnier; J Biollaz
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

10.  The effects of a converting enzyme inhibitor (captopril) and angiotensin II on fetal renal function.

Authors:  E R Lumbers; J H Burrell; R I Menzies; A D Stevens
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.